This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Wei Zhang
Director, Analytical Development at Ultragenyx Gene Therapy


Wei Zhang is currently Director of Analytical Development and CMC leader in Ultragenyx Gene Therapy. In Ultragenyx, Wei leads analytical method development and process and analytical development activities to support an early-stage gene therapy program. Wei is currently leading a late-stage CMC team devoted to post-commercial CMC activities. Prior to Ultragenyx, Wei was a scientist in Homology Medicines and Avitide Inc. Wei has extensive academic training in genomics and genetics.

Agenda Sessions

  • Apply Knowledge of the Structure-Function Relationship of scAAV in Control Strategy for Late-Stage Process Change